Ajing Xu

897 total citations
41 papers, 663 citations indexed

About

Ajing Xu is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Ajing Xu has authored 41 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Pharmacology. Recurrent topics in Ajing Xu's work include Circadian rhythm and melatonin (4 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Ajing Xu is often cited by papers focused on Circadian rhythm and melatonin (4 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Ajing Xu collaborates with scholars based in China, Japan and Australia. Ajing Xu's co-authors include Yan Liu, Kazuhiko Yanai, Atsuo Kuramasu, Eiko Sakurai, Hongmei Dai, Motohisa Kato, Jian Zhang, Nobuyuki Okamura, Satoshi Fujii and Zhong Chen and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Neurochemistry.

In The Last Decade

Ajing Xu

41 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ajing Xu China 15 229 173 74 73 69 41 663
Mitsunobu Mio Japan 17 291 1.3× 220 1.3× 53 0.7× 149 2.0× 79 1.1× 51 770
Jeoung‐Hee Ha South Korea 18 370 1.6× 163 0.9× 48 0.6× 92 1.3× 202 2.9× 41 1.2k
Lori M. N. Shimoda United States 13 222 1.0× 143 0.8× 154 2.1× 146 2.0× 228 3.3× 24 783
Attayeb Mohsen Japan 11 248 1.1× 114 0.7× 68 0.9× 57 0.8× 12 0.2× 25 512
Toshio Inui Japan 19 495 2.2× 91 0.5× 35 0.5× 132 1.8× 58 0.8× 59 1.1k
Satoko Yamada Japan 16 313 1.4× 47 0.3× 157 2.1× 49 0.7× 56 0.8× 42 904
Matthias Soddemann Germany 17 812 3.5× 100 0.6× 40 0.5× 154 2.1× 52 0.8× 32 1.1k
Kentaro Nishida Japan 17 195 0.9× 41 0.2× 47 0.6× 71 1.0× 59 0.9× 49 833
Jinlu Huang China 18 326 1.4× 80 0.5× 88 1.2× 144 2.0× 54 0.8× 41 879
Mai Hazekawa Japan 15 225 1.0× 46 0.3× 51 0.7× 173 2.4× 367 5.3× 47 931

Countries citing papers authored by Ajing Xu

Since Specialization
Citations

This map shows the geographic impact of Ajing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajing Xu more than expected).

Fields of papers citing papers by Ajing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ajing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajing Xu. The network helps show where Ajing Xu may publish in the future.

Co-authorship network of co-authors of Ajing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ajing Xu. A scholar is included among the top collaborators of Ajing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ajing Xu. Ajing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Shuyan, Xiaodong Xing, Jing Xie, et al.. (2025). Wogonoside ameliorates oxidative damage in tubular epithelial cells of diabetic nephropathy by modulating the HNF4A-NRF2 axis. International Immunopharmacology. 152. 114481–114481. 1 indexed citations
2.
Li, Mi, et al.. (2024). Advances in surface plasmon resonance for analyzing active components in traditional Chinese medicine. Journal of Pharmaceutical Analysis. 14(10). 100983–100983. 11 indexed citations
3.
Huang, Jinchang, Tao Zhang, Ajing Xu, et al.. (2024). Cyclo(L-Pro-L-Trp) from Chilobrachys jingzhao alleviates formalin-induced inflammatory pain by suppressing the inflammatory response and inhibiting TRAF6-mediated MAPK and NF-κB signaling pathways. International Immunopharmacology. 139. 112602–112602. 3 indexed citations
4.
Ma, Jing, Yongjian Zhang, Ajing Xu, et al.. (2023). Flower-like WSe2 used as bio-matrix in ultrasensitive label-free electrochemical immunosensor for human immunoglobulin G determination. Analytical Sciences. 39(8). 1391–1403. 3 indexed citations
5.
Chen, Dongxin, Haibo Zhang, Wenjuan Zhao, et al.. (2023). Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx. Frontiers in Pharmacology. 14. 1236469–1236469. 3 indexed citations
6.
Zhang, Ying, et al.. (2023). Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects. Biomedicine & Pharmacotherapy. 168. 115670–115670. 56 indexed citations
7.
Yao, Huijuan, Chao Li, Wei Sun, et al.. (2022). Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 6275505–6275505. 16 indexed citations
8.
Liu, Yan, Jihui Chen, You Yin, et al.. (2021). An ensemble learning based framework to estimate warfarin maintenance dose with cross-over variables exploration on incomplete data set. Computers in Biology and Medicine. 131. 104242–104242. 18 indexed citations
9.
10.
Zhang, Qiqiang, Qing Ye, Xiaohui Huang, et al.. (2020). Revealing active components, action targets and molecular mechanism of Gandi capsule for treating diabetic nephropathy based on network pharmacology strategy. BMC Complementary Medicine and Therapies. 20(1). 362–362. 15 indexed citations
11.
Ma, Jing, Xiaoyuan Xu, Haijing Yan, et al.. (2020). Lipopolysaccharide exposure induces oxidative damage in Caenorhabditis elegans: protective effects of carnosine. BMC Pharmacology and Toxicology. 21(1). 85–85. 14 indexed citations
12.
Wang, Lin, Yilong Zhou, Zijuan Chen, et al.. (2019). PLCβ2 negatively regulates the inflammatory response to virus infection by inhibiting phosphoinositide-mediated activation of TAK1. Nature Communications. 10(1). 746–746. 21 indexed citations
13.
Ma, Jing, Ranran Wang, Haijing Yan, et al.. (2019). Protective Effects of Baicalin on Lipopolysaccharide-Induced Injury in <b><i>Caenorhabditis elegans</i></b>. Pharmacology. 105(1-2). 109–117. 13 indexed citations
14.
Liu, Yan, You Yin, Xiaotong Lu, et al.. (2014). Association of ABCC2 −24C>T Polymorphism with High-Dose Methotrexate Plasma Concentrations and Toxicities in Childhood Acute Lymphoblastic Leukemia. PLoS ONE. 9(1). e82681–e82681. 47 indexed citations
15.
Huang, Xiaohui, et al.. (2014). Simultaneous determination of 50 residual pesticides in Flos Chrysanthemi using accelerated solvent extraction and gas chromatography. Journal of Chromatography B. 967. 1–7. 16 indexed citations
16.
Xu, Ajing, Guojun Shi, Feng Liu, & Baoxue Ge. (2012). Caenorhabditis elegans mom-4 is required for the activation of the p38 MAPK signaling pathway in the response to Pseudomonas aeruginosa infection. Protein & Cell. 4(1). 53–61. 12 indexed citations
17.
Xu, Ajing, Eiko Sakurai, Atsuo Kuramasu, et al.. (2010). Roles of Hypothalamic Subgroup Histamine and Orexin Neurons on Behavioral Responses to Sleep Deprivation Induced by the Treadmill Method in Adolescent Rats. Journal of Pharmacological Sciences. 114(4). 444–453. 22 indexed citations
18.
Kong, Lingzhao, Lei Sun, Hongxin Zhang, et al.. (2009). An Essential Role for RIG-I in Toll-like Receptor-Stimulated Phagocytosis. Cell Host & Microbe. 6(2). 150–161. 70 indexed citations
19.
Dai, Hongmei, Kenya Kaneko, Hiroshi Kato, et al.. (2006). Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors. Neuroscience Research. 57(2). 306–313. 108 indexed citations
20.
Zhu, Lijun, et al.. (2003). Spatiotemporal changes of the N-methyl-d-aspartate receptor subunit levels in rats with pentylenetetrazole-induced seizures. Neuroscience Letters. 356(1). 53–56. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsunobu Mio Breakdown of academic impact, for papers by Jeoung‐Hee Ha Breakdown of academic impact, for papers by Lori M. N. Shimoda Breakdown of academic impact, for papers by Attayeb Mohsen Breakdown of academic impact, for papers by Toshio Inui Breakdown of academic impact, for papers by Satoko Yamada Breakdown of academic impact, for papers by Matthias Soddemann Breakdown of academic impact, for papers by Kentaro Nishida Breakdown of academic impact, for papers by Jinlu Huang Breakdown of academic impact, for papers by Mai Hazekawa
Rankless by CCL
2026